Updated Jul 16, 2026
Smith Jason Drew is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $320K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-02-11 | URGN | UroGen Pharma Ltd. | S — Open-market sale | 3.2K | $19.69 | $63K |
| 2026-02-11 | URGN | UroGen Pharma Ltd. | M — Option exercise | 6.7K | — | |
| 2026-02-11 | URGN | UroGen Pharma Ltd. | S — Open-market sale | 1.6K | $19.69 | $32K |
| 2026-02-11 | URGN | UroGen Pharma Ltd. | M — Option exercise | 3.3K | — | |
| 2026-02-11 | URGN | UroGen Pharma Ltd. | S — Open-market sale | 2.7K | $19.69 | $52K |
| 2026-02-11 | URGN | UroGen Pharma Ltd. | M — Option exercise | 5.5K | — | |
| 2025-09-07 | URGN | UroGen Pharma Ltd. | S — Open-market sale | 1.5K | $19.11 | $29K |
| 2025-09-07 | URGN | UroGen Pharma Ltd. | M — Option exercise | 3.3K | — | |
| 2025-07-28 | URGN | UroGen Pharma Ltd. | S — Open-market sale | 7.5K | $19.14 | $144K |
| 2025-07-28 | URGN | UroGen Pharma Ltd. | M — Option exercise | 16.5K | — |
Smith Jason Drew is a corporate insider — currently tracked as General Counsel. InsiderAlpha tracks every SEC Form 4 filing in real time.
Recorded transactions: 0 open-market purchases () and 5 open-market sales ($320K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Smith Jason Drew profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.